GlassScriptPhysician profile
Ashish K Gupta
NPI 1265521470
$317,393.43
in general payments reported to CMS, 2019-2025
61 companies · $2,797 in 2025
The $2,797 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125K · 2020: $38K · 2021: $30K · 2022: $76K · 2023: $28K · 2024: $19K · 2025: $2,797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33K · Food and Beverage: $11K · Travel and Lodging: $4,553 · Honoraria: $1,600 · Education: $16.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,185.00 |
| Food and Beverage | $10,510.63 |
| Travel and Lodging | $4,552.88 |
| Honoraria | $1,600.00 |
| Education | $16.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $203,136.18 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61,650.20 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $9,348.20 | 2019-2024 | Mounjaro |
| Scpharmaceuticals INC. | $8,664.52 | 2023-2024 | |
| Cook Medical LLC | $6,267.27 | 2019-2023 | Zenith Alpha, Zilver Ptx |
| Philips North America LLC | $5,992.58 | 2019-2025 | (6554) Periph Vasc Undiv, (Bh4) Igt Devices Undivided, (Az7) Lasers |
| Cardiovascular Systems INC. | $2,819.70 | 2019 | |
| Bard Peripheral Vascular, INC. | $2,273.51 | 2020-2025 | Rotarexs 6 F X 135 Cm, Venclose Maven Catheter, Fluency Endovascular Stent Graft |
| Reflow Medical INC | $2,021.56 | 2023-2025 | |
| Penumbra, INC. | $1,636.62 | 2019-2022 | |
| Medtronic, INC. | $1,525.29 | 2021-2025 | Venaseal, Closurefast |
| Novartis Pharmaceuticals Corporation | $1,042.93 | 2019-2025 | |
| Cvrx, INC. | $1,004.27 | 2022-2025 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $856.95 | 2021-2025 | Uptravi, Opsumit |
| E.R. Squibb & Sons, L.L.C. | $765.40 | 2020-2025 | Camzyos, Eliquis |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $730.11 | 2019-2025 | Repatha, Repatha |
| Abiomed | $697.03 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $608.36 | 2021-2025 | Verquvo |
| Novo Nordisk INC | $527.65 | 2021-2025 | Ozempic, Wegovy |
| Abbott Laboratories | $522.29 | 2022-2025 | Cardiomems, Amplatzer Talisman, Ensite Precision |
| Impulse Dynamics (USA) INC. | $504.36 | 2022-2023 | Optimizer |
| Sanofi-Aventis U.S. LLC | $399.56 | 2019-2024 | |
| Boston Scientific Corporation | $375.19 | 2019-2025 | Varithena Administration Pack |
| Janssen Scientific Affairs, LLC | $369.53 | 2019-2023 | Xarelto |
| Cordis US Corp. | $365.29 | 2021-2024 | Mynx Venous Vcd, Mynx Control, Radial 360 |
| Esperion Therapeutics, INC. | $323.51 | 2020-2023 | Nexletol |
| Amarin Pharma, INC. | $260.54 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $255.32 | 2020-2025 | Farxiga |
| Heartflow, INC. | $225.63 | 2024-2025 | |
| Pfizer INC. | $218.50 | 2019-2025 | |
| Inari Medical, INC. | $200.00 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $194.83 | 2021-2025 | |
| Endologix LLC | $193.49 | 2025 | Torus Stent Graft System, Endocross Device |
| Asahi Intecc USA, INC. | $156.52 | 2022 | |
| Shockwave Medical, INC | $148.09 | 2020-2021 | |
| Cardinal Health 200 LLC | $136.11 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $125.50 | 2023-2025 | Lifevest |
| Smith+Nephew, INC. | $114.99 | 2022 | |
| Siemens Medical Solutions USA, INC. | $110.72 | 2020 | |
| Celonova Biosciences, INC. | $100.00 | 2019 | |
| Tactile Systems Technology INC | $83.27 | 2020-2022 | |
| Alnylam Pharmaceuticals INC. | $72.54 | 2021-2025 | Amvuttra |
| W. L. Gore & Associates, INC. | $68.76 | 2019-2020 | |
| Elutia, INC. | $59.91 | 2021-2022 | |
| Medtronic Vascular, INC. | $42.68 | 2019 | |
| Atricure, INC. | $32.75 | 2025 | Synergy Ablation System |
| Daiichi Sankyo INC. | $27.74 | 2023-2025 | Injectafer |
| Veryan Medical Incorporated | $27.40 | 2020 | |
| Arbor Pharmaceuticals, INC. | $25.41 | 2020-2021 | |
| United Therapeutics Corporation | $21.67 | 2024 | Tyvaso |
| Kowa Pharmaceuticals America, INC. | $18.48 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $17.21 | 2023 | Evkeeza |
| Edwards Lifesciences Corporation | $14.59 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $12.72 | 2023 | Inpefa |
7 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.